U.S. Markets close in 1 hr 56 mins

Imprimis Pharmaceuticals, Inc. (IMMY)

NASDAQ Capital Market - NASDAQ Capital Market Real Time Price. Currency in USD
Add to watchlist
2.11-0.11 (-4.95%)
As of 1:58PM EDT. Market open.
People also watch
Full screen
Previous Close2.22
Bid2.11 x 900
Ask2.14 x 3000
Day's Range2.10 - 2.22
52 Week Range1.65 - 4.69
Avg. Volume199,918
Market Cap42.34M
PE Ratio (TTM)-1.60
EPS (TTM)-1.32
Earnings DateNov 13, 2017 - Nov 17, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
Trade prices are not sourced from all markets
  • Associated Press12 days ago

    Imprimis posts 2Q profit

    On a per-share basis, the San Diego-based company said it had net income of 6 cents. The pharmaceutical and drug compounding company posted revenue of $6.9 million in the period. In the final minutes of ...

  • Imprimis Pharmaceuticals Announces Second Quarter 2017 Financial Results
    PR Newswire12 days ago

    Imprimis Pharmaceuticals Announces Second Quarter 2017 Financial Results

    SAN DIEGO , Aug. 10, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today reported financial results for the second quarter 2017.  ...

  • ACCESSWIRE12 days ago

    Investor Network: Imprimis Pharmaceuticals, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 10, 2017 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 10, 2017 ...